Lynx Investment Advisory Bio Rad Laboratories, Inc. Transaction History
Lynx Investment Advisory
- $135 Billion
- Q2 2024
A detailed history of Lynx Investment Advisory transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Lynx Investment Advisory holds 2 shares of BIO stock, worth $716. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2Holding current value
$716% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
460Shares Held
20.2MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$851 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$555 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$467 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$389 Million3.03% of portfolio
-
State Street Corp Boston, MA860KShares$308 Million0.01% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.82B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...